Content about Collaborative Care

February 3, 2012
American Diabetes Association appoints chief scientific and medical officer

The American Diabetes Association has appointed Robert Ratner to serve as chief scientific and medical officer of the organization, effective May 7.

February 3, 2012
Max-Wellness launches healthcare kiosks, revamps website offering

Max-Wellness is preparing to introduce its “Wellness-in-a-Box” concept — an automated dispensing device located in a variety of unique venues featuring health-and-wellness products that customers can purchase at any time using a debit or credit card. The concept is slated to make its debut in March, the company stated.

February 3, 2012
Performance booster supplement DMAA draws national media attention

The Department of Defense investigation's of a sports supplement ingredient — associated with the death of two soldiers — has been making headlines in the past week as the U.S. Military's independent paper Stars & Stripes ran an update of the news on Jan. 29 and the New York Times picked up on the story Feb. 2.

February 3, 2012
Regulatory waiting period for Bristol's Inhibitex acquisition expires

The regulatory waiting period standing between Bristol-Myers Squibb and its acquisition of drug maker Inhibitex has expired, giving Bristol the green light to buy the company.

February 3, 2012
Study: Bausch + Lomb's Biotrue helps maintain tear film's natural antibacterial activity

A study on Bausch + Lomb's Biotrue multipurpose contact lens solution published in the January edition of the journal Eye & Contact Lens: Science & Clinical Practice found that the solution can help improve eye health.

February 3, 2012
Survey: Endocrinologists would prescribe Bydureon for 20% of patients

Endocrinologists would prescribe a newly approved weekly treatment for Type 2 diabetes to one-fifth of their patients, a new survey showed.

February 3, 2012
Teva launches generic schizophrenia, bipolar disorder drug

Teva Pharmaceuticals has launched a generic version of a psychiatric drug, the company said Friday.

February 2, 2012
FDA approves Merck diabetes drug

The Food and Drug Administration has approved a drug made by Merck for Type 2 diabetes, the drug maker said Thursday.

February 2, 2012
Mylan wins tentative approval for generic Lipitor

The Food and Drug Administration has given tentative approval to a generic cholesterol drug made by Mylan, the drug maker said Thursday.

February 2, 2012
PhRMA: More than 50 drugs in development for COPD

More than 50 drugs are under development for treating a respiratory disease that is the third-leading cause of death in the United States.

February 2, 2012
Rite Aid comps rise 2.2% in January

Rite Aid's comps increased 2.2% for the month of January, compared with January 2011, the company said Thursday.

February 2, 2012
Statement: Walgreens a differentiating factor in Medicare Part D plans

Medicare Part D plans that had incorporated Walgreens into their network gained market share last year, while those without Walgreens collectively lost market share, according to a Walgreens statement issued Wednesday.

February 2, 2012
Walgreens fortifies its specialty pharmacy arm

Walgreens on Thursday inserted another piece into its comprehensive healthcare offering, just in time for the PBM selling season, with the acquisition of BioScrip's community specialty pharmacies.

February 1, 2012
CBO: Government health spending to hit $1.8 trillion

A projection issued by the Congressional Budget Office concluded that healthcare spending in the United States would reach a substantial high.

February 1, 2012
Far from child's play with fevers, parents at a loss

Parents and doctors agree: When it comes to a child’s fever, most parents don’t know what to do.

February 1, 2012
FDA approves new indication for Novartis' Gleevec

The Food and Drug Administration has approved a drug made by Novartis that is designed to prevent tumors in the gastrointestinal tract from recurring after surgical removal, the agency said.

February 1, 2012
Flu season in swing: Vaccine good protection

Through the first week of the New Year, incidence of flu was on a slight incline but still relatively low. Only two states, Alabama and Louisiana, reported a measured rise in influenza-like illnesses.

February 1, 2012
Fortunate drive that sparked an industry

Ever wonder how the convenient care industry blossomed into what it is today? One could say a fortune cookie.

February 1, 2012
Heart disease, hypertension, high cholesterol still extremely prevalent

Of all the diseases labeled “silent killers,” heart disease is the one that gets that epithet most often. According to the National Center for Health Statistics, since 1900, there has been only one year in which heart disease wasn’t the deadliest disease in the country.

February 1, 2012
Impax licenses migraine drug rights from AstraZeneca

Impax Pharmaceuticals said Wednesday that it obtained exclusive U.S. commercial rights to a drug for migraine headaches made by AstraZeneca.

February 1, 2012
Lilly Diabetes donates diabetes camp scholarships

Through a collaboration with the American Diabetes Association, the diabetes division of drug maker Eli Lilly has committed to send 89 children to diabetes camp this summer.

February 1, 2012
Lipitor foreshadows approaching patent cliff for other leading drugs

For the past several years, drug industry experts have spoken in terms of the “patent cliff,” the period when the patents covering several blockbuster drugs are set to expire, thus leaving their manufacturers with a big, gaping hole in their revenues as those drugs face competition from generics.

February 1, 2012
NACDS Foundation releases second wave of funding via Community PREP

The charitable arm of the National Association of Chain Drug Stores once again has released funding that will support 15 new residencies for recent pharmacy graduates.

February 1, 2012
Pfizer recalls 28 lots of branded, generic oral contraceptive

A possible pill mix-up has prompted Pfizer to recall more than two dozen lots of a prescription contraceptive drug, the drug maker said.

February 1, 2012
Rite Aid launches heart health campaign

Rite Aid is marking American Heart Month with a campaign that offers blood-pressure screenings, online tools and hearth health guides for free, the company said Wednesday.

© 2013 Drug Store News. All Rights Reserved.